Genentech Profit Climbs

PepsiCo posts higher net; Manor Care sees EPS shortfall; plus more of Tuesday's stocks in the news

Genentech (DNA ) posted second quarter earnings per share (non-GAAP basis) of 30 cents, vs. 19 cents one year earlier, on a 35% rise in operating revenue and 39% higher total product sales.The biotech outfit expects 2005 non-GAAP EPS to increase by more than 35%.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.